Natera Gross Margin 2014-2023 | NTRA
Current and historical gross margin for Natera (NTRA) over the last 10 years. The current gross profit margin for Natera as of December 31, 2023 is %.
| Natera Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $1.08B | $0.49B | 45.56% |
| 2023-09-30 | $0.99B | $0.42B | 42.81% |
| 2023-06-30 | $0.93B | $0.40B | 42.53% |
| 2023-03-31 | $0.87B | $0.37B | 42.28% |
| 2022-12-31 | $0.82B | $0.36B | 44.39% |
| 2022-09-30 | $0.78B | $0.35B | 45.49% |
| 2022-06-30 | $0.72B | $0.34B | 46.47% |
| 2022-03-31 | $0.67B | $0.31B | 46.93% |
| 2021-12-31 | $0.63B | $0.31B | 49.28% |
| 2021-09-30 | $0.56B | $0.28B | 49.82% |
| 2021-06-30 | $0.50B | $0.25B | 49.60% |
| 2021-03-31 | $0.45B | $0.22B | 50.00% |
| 2020-12-31 | $0.39B | $0.19B | 47.95% |
| 2020-09-30 | $0.36B | $0.17B | 48.20% |
| 2020-06-30 | $0.34B | $0.16B | 47.51% |
| 2020-03-31 | $0.33B | $0.15B | 46.50% |
| 2019-12-31 | $0.30B | $0.13B | 42.38% |
| 2019-09-30 | $0.29B | $0.11B | 39.51% |
| 2019-06-30 | $0.27B | $0.10B | 37.73% |
| 2019-03-31 | $0.26B | $0.09B | 35.88% |
| 2018-12-31 | $0.26B | $0.09B | 35.80% |
| 2018-09-30 | $0.24B | $0.08B | 34.30% |
| 2018-06-30 | $0.23B | $0.08B | 34.33% |
| 2018-03-31 | $0.22B | $0.08B | 34.23% |
| 2017-12-31 | $0.21B | $0.07B | 33.49% |
| 2017-09-30 | $0.20B | $0.06B | 30.69% |
| 2017-06-30 | $0.20B | $0.06B | 30.50% |
| 2017-03-31 | $0.20B | $0.06B | 32.00% |
| 2016-12-31 | $0.21B | $0.08B | 36.62% |
| 2016-09-30 | $0.22B | $0.09B | 41.63% |
| 2016-06-30 | $0.21B | $0.09B | 40.57% |
| 2016-03-31 | $0.21B | $0.08B | 40.98% |
| 2015-12-31 | $0.19B | $0.08B | 40.53% |
| 2015-06-30 | $0.14B | $0.07B | 48.55% |
| 2015-03-31 | $0.13B | $0.07B | 50.39% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.205B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.869B | 15.67 |
| Cencora (COR) | United States | $48.051B | 19.18 |
| ICON (ICLR) | Ireland | $25.434B | 24.01 |
| DiDi Global (DIDIY) | China | $24.387B | 0.00 |
| Avantor (AVTR) | United States | $16.238B | 23.94 |
| Viatris (VTRS) | United States | $13.880B | 3.96 |
| CochLear (CHEOY) | $13.776B | 0.00 | |
| Revvity (RVTY) | United States | $12.539B | 21.83 |
| Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
| Charles River Laboratories (CRL) | United States | $11.798B | 21.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
| Solventum (SOLV) | United States | $11.115B | 0.00 |
| HealthEquity (HQY) | United States | $6.886B | 51.45 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
| Organon (OGN) | United States | $4.742B | 4.59 |
| Doximity (DOCS) | United States | $4.444B | 33.08 |
| PACS (PACS) | United States | $3.713B | 0.00 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Surgery Partners (SGRY) | United States | $3.108B | 28.88 |
| Progyny (PGNY) | United States | $3.079B | 51.68 |
| GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
| Life Times (LTH) | United States | $2.783B | 30.76 |
| Premier (PINC) | United States | $2.511B | 9.19 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
| Agilon Health (AGL) | United States | $2.055B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| NovoCure (NVCR) | Jersey | $1.360B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
| Embecta (EMBC) | United States | $0.594B | 3.92 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.503B | 45.59 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
| LifeMD (LFMD) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
| Beauty Health (SKIN) | United States | $0.400B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| MultiPlan (MPLN) | United States | $0.371B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
| ModivCare (MODV) | United States | $0.335B | 4.44 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| Biodesix (BDSX) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.125B | 41.83 |
| Oncology Institute (TOI) | United States | $0.085B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |